Clinical Trial Update: Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the combination of docetaxel, estramustine, and thalidomide in men with prostate cancer previously treated with hormone therapy. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Estramustine (estramustine)
• Thalidomide (thalidomide)

Snippet

Sponsor: Nuvance Health | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED